Success Metrics

Clinical Success Rate
91.3%

Based on 73 completed trials

Completion Rate
91%(73/80)
Active Trials
3(3%)
Results Posted
34%(25 trials)
Terminated
7(7%)

Phase Distribution

Ph phase_1
28
29%
Ph phase_2
18
19%
Ph phase_3
17
18%
Ph phase_4
22
23%
Ph early_phase_1
1
1%
Ph not_applicable
6
6%

Phase Distribution

29

Early Stage

18

Mid Stage

39

Late Stage

Phase Distribution92 total trials
Early Phase 1First-in-human
1(1.1%)
Phase 1Safety & dosage
28(30.4%)
Phase 2Efficacy & side effects
18(19.6%)
Phase 3Large-scale testing
17(18.5%)
Phase 4Post-market surveillance
22(23.9%)
N/ANon-phased studies
6(6.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.0%

73 of 83 finished

Non-Completion Rate

12.0%

10 ended early

Currently Active

3

trials recruiting

Total Trials

95

all time

Status Distribution
Active(3)
Completed(73)
Terminated(10)
Other(9)

Detailed Status

Completed73
unknown9
Terminated7
Withdrawn3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
95
Active
3
Success Rate
91.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.1%)
Phase 128 (30.4%)
Phase 218 (19.6%)
Phase 317 (18.5%)
Phase 422 (23.9%)
N/A6 (6.5%)

Trials by Status

completed7377%
recruiting22%
unknown99%
active_not_recruiting11%
terminated77%
withdrawn33%

Recent Activity

Clinical Trials (95)

Showing 20 of 95 trialsScroll for more
NCT06494111Phase 2

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Recruiting
NCT03944512Phase 3

Pravastatin to Prevent Preeclampsia

Terminated
NCT04284657Phase 2

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Completed
NCT03273413Phase 4

Statin Therapy in Patients With Early Stage ADPKD

Active Not Recruiting
NCT01717586Phase 1

Pravastatin for Prevention of Preeclampsia

Completed
NCT05524246Phase 1

Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

Completed
NCT04356209Phase 2

Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life

Recruiting
NCT00829309Phase 1

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

Completed
NCT00648544Phase 1

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

Completed
NCT00650221Phase 1

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

Completed
NCT05852769Phase 1

A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

Completed
NCT03882177Phase 2

StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis

Completed
NCT03456102Phase 2

Statin Adjunctive Therapy for TB

Completed
NCT04190433Phase 2

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Withdrawn
NCT03510884Phase 3

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Completed
NCT02484261Phase 1

Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children

Terminated
NCT02841774Phase 2

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV

Completed
NCT02871687Phase 1

Effect of Statin Use on Aldosterone Secretion

Completed
NCT04608344Phase 1

Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants

Completed
NCT05107063

An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes

Completed

Drug Details

Intervention Type
DRUG
Total Trials
95